Bioxyne Ltd: Response to ASX Query Letter
Bioxyne Ltd: Pause in Trading
Bioxyne Ltd: BXN Manufactures First Pharmaceutical Cannabis Gummies
Bioxyne Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Ltd: Addendum to Cy Biopharma Announcement 14.5.2024
Bioxyne Ltd: BXN Signs Collaboration Agreement with Cy Biopharma AG
Bioxyne Ltd: Shares Out of Escrow
Bioxyne Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Ltd: Bioxyne Receives Firm Commitments to Raise $1.45 Million
Bioxyne Ltd: Bioxyne to Host Webinar on 28 March 2024
Bioxyne Ltd: BXN Awarded GMP Manufacturing License for Medical Cannabis
Bioxyne Ltd: Quarterly Report Listing Rule 4.7C.3
Bioxyne Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Ltd: Final Director's Interest Notice
Bioxyne Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Bioxyne Ltd: BLS Builds Medicinal Business In Australia
Bioxyne Ltd: Change of Director's Interest Notice
Bioxyne Ltd: Change of Director's Interest Notice
Bioxyne Ltd: AGM Date 2023 and Closing Date for Director Nominations
Bioxyne Ltd: Appendix 4G and Corporate Governance Statement
No Data